Target intelligence / Profile preview

TATA-box binding protein associated factor 2 (TAF2)

Target
TAF2
Molecular classification
Transcription factor, TBP-associated factor, Subunit of transcription initiation factor TFIID, Histone-like protein fold domain
01

Overview

TATA-box binding protein associated factor 2 (TAF2) is a protein encoded by the *TAF2* gene in humans and is a major subunit of the transcription factor IID (TFIID) complex. TFIID is essential for the initiation of transcription by RNA polymerase II, serving as a scaffold for the assembly of the pre-initiation complex and a conduit for regulatory signals during promoter activation. TAF2 is stably associated with TFIID and contributes to promoter DNA binding, interacting at and downstream of transcription start sites to facilitate transcription complex responsiveness to activators. Structurally, TAF2 contains a histone-like fold domain, contributing to protein-protein interactions within TFIID. Pathogenic variants in TAF2 can result in neurodevelopmental disorders, including leukodystrophy. TAF2 is not a direct therapeutic target and no drugs are known to modulate its activity.

Other names
TAFII150CIF150TAF2BTAFIIBMRT40150 kDa cofactor of initiator functionTranscription initiation factor TFIID 150 kDa subunitRNA polymerase II TBP-associated factor subunit BTATA box binding protein (TBP)-associated factor, 150 kDaTAF2 RNA polymerase II
02

Biological functions

Basal transcription initiationPromoter recognitionCoactivator functionAssembly of the pre-initiation complexFacilitating interactions with transcriptional activators and general transcription factorsModifying transcription complex response
03

Disease associations

Neurodevelopmental disorder (with feeding difficulties, thin corpus callosum, and foot deformity)LeukodystrophyDefects may impact gene expression globally and could be associated with additional neurological or developmental syndromes
04

Safety considerations

Notable safety concerns are unknown, as TAF2 is not a drug target. However, dysregulation can theoretically cause widespread effects on gene expression, potentially leading to developmental or neurodegenerative disorders

Beyond the preview

Go deeper on TATA-box binding protein associated factor 2 (TAF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TATA-box binding protein associated factor 2 (TAF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call